573 related articles for article (PubMed ID: 25653131)
1. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
[TBL] [Abstract][Full Text] [Related]
2. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
[TBL] [Abstract][Full Text] [Related]
3. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
5. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
[TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
[TBL] [Abstract][Full Text] [Related]
7. Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Infect Genet Evol; 2012 Jan; 12(1):38-44. PubMed ID: 22020253
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
[TBL] [Abstract][Full Text] [Related]
10. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
[TBL] [Abstract][Full Text] [Related]
12. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A
Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
Ruh E; Bateko JP; Imir T; Taylan-Ozkan A
Malar J; 2018 Jan; 17(1):17. PubMed ID: 29316929
[TBL] [Abstract][Full Text] [Related]
14. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
15. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
[TBL] [Abstract][Full Text] [Related]
16. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
Fernandes N; Figueiredo P; do Rosário VE; Cravo P
Malar J; 2007 Mar; 6():35. PubMed ID: 17378942
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
Zakeri S; Farahani MS; Afsharpad M; Salehi M; Raeisi A; Djadid ND
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e123-8. PubMed ID: 20399698
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
